We are looking for young people 2–17 years old to join a Crohn’s disease research study to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or moderately to severely active IBD (including associated symptoms such as rectal bleeding, loss of appetite, cramps, chronic fatigue and/or canker sores), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
